Daejoo대주산업

Daejoo's trailing earnings are steady but below 2024 levels, while the share price has fallen 9.3% over the past month.

Daejoo, a Korean maker of compound animal feed and pet food with an animal medicine subsidiary, reported trailing twelve-month revenue of ₩100.8B and operating income of ₩10.5B to H1 2026, with a 10.4% operating margin. Revenue fell 4.8% in 2025, and net income has declined from ₩10.1B in 2023 to ₩6.4B on a trailing basis. The shares trade at about 8.3 times earnings and 0.5 times book value, with a 2.5% dividend yield, and the stock is near the low end of its 52-week range.

What stands out

• Trailing operating margin of 10.4% is up from 9.5% in 2024 and 7.3% in 2023, but net income has fallen each year since 2023.
• Cash of ₩8.6B exceeds borrowings of ₩5.0B, and liabilities are 29.3% of equity, so the balance sheet looks conservative on these figures.
• Free cash flow on a trailing basis was ₩11.1B, above reported net income of ₩6.4B.
• The DCF-based fair value model gives a base value of ₩3,124 against a close of ₩1,495, though the bear case is ₩1,819 and the bull case is ₩5,360; these are model outputs, not forecasts.
• Foreign ownership rose slightly to 9.5% from 9.2% over 60 days, while retail and institutional investors were net sellers over the past 20 days.

What to watch

• The next quarterly and annual filings, to see whether margins hold and net income recovers from the trailing decline.
• Insider shareholding reports and any further dividend decisions, given the 2.5% yield.
• Trading volatility: the share price is down 9.3% over one month and well below its 52-week high of ₩6,090. No recent news headlines were available in the data.